CRP and sarcopenia: Although most previous studies hypothesized that sarcopenia might reflect an increased catabolic activity associated with most aggressive tumors (which involves inflammation and related muscle wasting), they did not assess the levels of inflammatory variables (such as CRP and proinflammatory cytokines) as potential catabolic drivers.